457 related articles for article (PubMed ID: 12682240)
1. A subset of Toll-like receptor ligands induces cross-presentation by bone marrow-derived dendritic cells.
Datta SK; Redecke V; Prilliman KR; Takabayashi K; Corr M; Tallant T; DiDonato J; Dziarski R; Akira S; Schoenberger SP; Raz E
J Immunol; 2003 Apr; 170(8):4102-10. PubMed ID: 12682240
[TBL] [Abstract][Full Text] [Related]
2. Alternate class I MHC antigen processing is inhibited by Toll-like receptor signaling pathogen-associated molecular patterns: Mycobacterium tuberculosis 19-kDa lipoprotein, CpG DNA, and lipopolysaccharide.
Tobian AA; Potter NS; Ramachandra L; Pai RK; Convery M; Boom WH; Harding CV
J Immunol; 2003 Aug; 171(3):1413-22. PubMed ID: 12874233
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor ligands directly promote activated CD4+ T cell survival.
Gelman AE; Zhang J; Choi Y; Turka LA
J Immunol; 2004 May; 172(10):6065-73. PubMed ID: 15128790
[TBL] [Abstract][Full Text] [Related]
4. Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus- and HIV-1-specific T cell responses.
Loré K; Betts MR; Brenchley JM; Kuruppu J; Khojasteh S; Perfetto S; Roederer M; Seder RA; Koup RA
J Immunol; 2003 Oct; 171(8):4320-8. PubMed ID: 14530357
[TBL] [Abstract][Full Text] [Related]
5. Endotoxin-induced maturation of MyD88-deficient dendritic cells.
Kaisho T; Takeuchi O; Kawai T; Hoshino K; Akira S
J Immunol; 2001 May; 166(9):5688-94. PubMed ID: 11313410
[TBL] [Abstract][Full Text] [Related]
6. TLR ligands can activate dendritic cells to provide a MyD88-dependent negative signal for Th2 cell development.
Sun J; Walsh M; Villarino AV; Cervi L; Hunter CA; Choi Y; Pearce EJ
J Immunol; 2005 Jan; 174(2):742-51. PubMed ID: 15634894
[TBL] [Abstract][Full Text] [Related]
7. A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells.
Dillon S; Agrawal A; Van Dyke T; Landreth G; McCauley L; Koh A; Maliszewski C; Akira S; Pulendran B
J Immunol; 2004 Apr; 172(8):4733-43. PubMed ID: 15067049
[TBL] [Abstract][Full Text] [Related]
8. T cells induce extended class II MHC compartments in dendritic cells in a Toll-like receptor-dependent manner.
Boes M; Bertho N; Cerny J; Op den Brouw M; Kirchhausen T; Ploegh H
J Immunol; 2003 Oct; 171(8):4081-8. PubMed ID: 14530329
[TBL] [Abstract][Full Text] [Related]
9. Cutting edge: generation of splenic CD8+ and CD8- dendritic cell equivalents in Fms-like tyrosine kinase 3 ligand bone marrow cultures.
Naik SH; Proietto AI; Wilson NS; Dakic A; Schnorrer P; Fuchsberger M; Lahoud MH; O'Keeffe M; Shao QX; Chen WF; Villadangos JA; Shortman K; Wu L
J Immunol; 2005 Jun; 174(11):6592-7. PubMed ID: 15905497
[TBL] [Abstract][Full Text] [Related]
10. TLR-independent induction of dendritic cell maturation and adaptive immunity by negative-strand RNA viruses.
López CB; Moltedo B; Alexopoulou L; Bonifaz L; Flavell RA; Moran TM
J Immunol; 2004 Dec; 173(11):6882-9. PubMed ID: 15557183
[TBL] [Abstract][Full Text] [Related]
11. The adjuvanticity of a mannosylated antigen reveals TLR4 functionality essential for subset specialization and functional maturation of mouse dendritic cells.
Sheng KC; Kalkanidis M; Pouniotis DS; Wright MD; Pietersz GA; Apostolopoulos V
J Immunol; 2008 Aug; 181(4):2455-64. PubMed ID: 18684936
[TBL] [Abstract][Full Text] [Related]
12. Myeloid differentiation factor 88 is required for cross-priming in vivo.
Palliser D; Ploegh H; Boes M
J Immunol; 2004 Mar; 172(6):3415-21. PubMed ID: 15004140
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of IL-10 receptor function in alveolar macrophages by Toll-like receptor agonists.
Fernandez S; Jose P; Avdiushko MG; Kaplan AM; Cohen DA
J Immunol; 2004 Feb; 172(4):2613-20. PubMed ID: 14764735
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor 3 mediates a more potent antiviral response than Toll-like receptor 4.
Doyle SE; O'Connell R; Vaidya SA; Chow EK; Yee K; Cheng G
J Immunol; 2003 Apr; 170(7):3565-71. PubMed ID: 12646618
[TBL] [Abstract][Full Text] [Related]
15. CpG DNA induces maturation of dendritic cells with distinct effects on nascent and recycling MHC-II antigen-processing mechanisms.
Askew D; Chu RS; Krieg AM; Harding CV
J Immunol; 2000 Dec; 165(12):6889-95. PubMed ID: 11120813
[TBL] [Abstract][Full Text] [Related]
16. Intracellular bacterial infection-induced IFN-gamma is critically but not solely dependent on Toll-like receptor 4-myeloid differentiation factor 88-IFN-alpha beta-STAT1 signaling.
Rothfuchs AG; Trumstedt C; Wigzell H; Rottenberg ME
J Immunol; 2004 May; 172(10):6345-53. PubMed ID: 15128825
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptors as adjuvant receptors.
Kaisho T; Akira S
Biochim Biophys Acta; 2002 Feb; 1589(1):1-13. PubMed ID: 11909637
[TBL] [Abstract][Full Text] [Related]
18. Facilitated antigen uptake and timed exposure to TLR ligands dictate the antigen-presenting potential of plasmacytoid DCs.
Kool M; Geurtsvankessel C; Muskens F; Madeira FB; van Nimwegen M; Kuipers H; Thielemans K; Hoogsteden HC; Hammad H; Lambrecht BN
J Leukoc Biol; 2011 Dec; 90(6):1177-90. PubMed ID: 21934071
[TBL] [Abstract][Full Text] [Related]
19. Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type 1 and 2 cell development: dependency on antigen dose and differential toll-like receptor ligation.
Boonstra A; Asselin-Paturel C; Gilliet M; Crain C; Trinchieri G; Liu YJ; O'Garra A
J Exp Med; 2003 Jan; 197(1):101-9. PubMed ID: 12515817
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor 2 (TLR2) and TLR9 signaling results in HIV-long terminal repeat trans-activation and HIV replication in HIV-1 transgenic mouse spleen cells: implications of simultaneous activation of TLRs on HIV replication.
Equils O; Schito ML; Karahashi H; Madak Z; Yarali A; Michelsen KS; Sher A; Arditi M
J Immunol; 2003 May; 170(10):5159-64. PubMed ID: 12734363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
